INDP
INDP
NASDAQ · Biotechnology

Indaptus Therapeutics Inc

$1.80
+0.25 (+16.13%)
As of Feb 8, 2:33 PM ET ·
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 1.71M 1.62M 1.61M
Net Income -161,760 -172,924 -142,728
EPS
Profit Margin -9.5% -10.7% -8.9%
Rev Growth +0.4% +1.6% -5.5%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 609.3K 545.1K 593.7K
Total Equity 2.31M 2.18M 2.44M
D/E Ratio 0.26 0.25 0.24
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA -256,082 -275,942 -257,647
Free Cash Flow -132,527 -99,336 -105,630